TRU-SENTIMENT ยท DeltaNeutral
HUM Trading Analysis - 10/07/2026 04:30 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
HUM (Humana Inc.) at $395.24. True Sentiment Bearish, delta 40-60 call 35% / put 65%, call $2,226,350 vs put $4,139,420. RSI 61.0.
- Symbol
- HUM
- Price
- $395.24
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-10-07 16:30:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From TRUE SENTIMENT OPTIONS (2026-10-07 16:29):
Call Volume: $2,226,350 (35.0%) Put Volume: $4,139,420 (65.0%) Total: $6,365,770
Sentiment is Bearish. Call contracts 868 vs put 1504; call trades 61 vs put 38. Pure directional conviction skews to puts. This diverges from bullish technicals (SMA/MACD/RSI). Near-term expectations from delta-validated flow imply defensive positioning or hedging into weakness.
Key Statistics: HUM
Fundamental Snapshot
Valuation
| P/E (trailing) | 37.90 |
| EPS (trailing 12 mo) | $10.66 |
| Market cap | $47.61B |
| Shares outstanding | 120.1M |
Dividend
| Dividend yield | 0.88% |
| Annual dividend | $3.54 |
| Ex-dividend date | 2026-10-30 |
Risk & range
| Beta | 1.38 |
| 52-week low | $163.11 |
| 52-week high | $428.88 |
| Historical volatility | 29.4% |
Ownership & trading
| Institutional ownership | 73.7% |
| Average daily volume | 1.1M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
Recent general-knowledge context for Humana (HUM) suggests the following thematic headlines that may relate to the provided data:
- Humana faces ongoing Medicare Advantage regulatory scrutiny as CMS finalizes 2027 payment rate adjustments, creating sector-wide uncertainty.
- Managed care names including HUM saw volatility tied to medical cost trend commentary in recent industry conferences.
- HUM's ex-dividend date is scheduled for 2026-10-30 with a dividend rate of $3.54, a near-term shareholder event.
- Broader healthcare policy headlines around drug pricing and MA star ratings have acted as overhangs for HUM sentiment.
- Institutional ownership remains elevated at 73.71%, suggesting steady large-cap sponsorship despite options bearishness.
Context: The headlines reflect defensive-sector pressure and policy risk, which may explain the bearish options sentiment even as technical indicators show bullish price structure. This external context is separated from the strict data analysis below.
Fundamental Analysis
Based strictly on the embedded FUNDAMENTALS data for HUM:
- Trailing P/E is 37.90 with trailing EPS of $10.66; valuation is elevated versus broad-market averages but typical for managed-care relative peers.
- Dividend yield is 0.88% with rate $3.54 and ex-dividend 2026-10-30; low yield indicates income is not the primary draw.
- Market cap is $47,612,920,800 with shares outstanding of 120,080,000 and institutional ownership at 73.71%.
- Beta is 1.38, implying above-market sensitivity; 52-week range is $163.11 to $428.88, price near upper half.
- Historical volatility is 29.37%; average volume 1,149,000 vs 20-day avg 715,775 in indicators.
- PEG, forward P/E, P/B, revenue, margins, ROE, D/E, FCF, and analyst target are null โ no growth or profitability ratios available in data.
- Fundamentals show large-cap stability and high institutional base, diverging from bearish options flow but aligned with bullish technical SMAs.
Current Market Position
From minute bars (2026-10-06 to 2026-10-07 15:55), first bar open was $405.02 and last close was $395.24. Daily history shows 2026-10-06 close at $404.43 with high $408.04 and low $396.04; prior day 2026-10-05 closed $402.44. The stock faded from $404.43 to $395.24 intraday on 10-07, with volume expanding to 92,843 in the final bar vs 29,944 in the opening bar.
Intraday momentum is negative: price made lower highs and lower lows into the close, with volume rising on the down bar.
Technical Analysis
Technical Indicators
Price is above SMA 5 ($391.98), SMA 20 ($390.53), and SMA 50 ($386.18) โ bullish alignment with no bearish crossover. RSI 60.96 shows moderate bullish momentum without overbought (>70). MACD (0.98) above signal (0.79) with positive histogram (0.20) confirms bullish bias. Bollinger mid $390.53, upper $412.49, lower $368.58; price $404.43 is in upper third, no squeeze. 30-day range high $419.97, low $369.13; current sits ~72% up the range.
True Sentiment Analysis (Delta 40-60 Options)
From TRUE SENTIMENT OPTIONS (2026-10-07 16:29):
Call Volume: $2,226,350 (35.0%) Put Volume: $4,139,420 (65.0%) Total: $6,365,770
Sentiment is Bearish. Call contracts 868 vs put 1504; call trades 61 vs put 38. Pure directional conviction skews to puts. This diverges from bullish technicals (SMA/MACD/RSI). Near-term expectations from delta-validated flow imply defensive positioning or hedging into weakness.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.